| Identification | Back Directory | [Name]
H-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2 | [CAS]
144025-82-1 | [Synonyms]
PACAP (16-38) (HUMAN, OVINE, RAT)
PACAP-38 (16-38), HUMAN, OVINE, RAT
PACAP-38 (16-38), human, mouse, rat
PACAP-38 (16-38) (HUMAN, CHICKEN, MOUSE, OVINE, PORCINE, RAT)
PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE-38 (16-38), HUMAN, OVINE, RAT
PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE (16-38) (HUMAN, OVINE, RAT)
GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2
H-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2
PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38 (16-38) (HUMAN, CHICKEN, MOUSE, OVINE, PORCINE, RAT)
GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2: QMAVKKYLAAVLGKRYKQRVKNK-NH2
L-Lysinamide,L-glutaminyl-L-methionyl-L-alanyl-L-valyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-alanyl-L-alanyl-L-valyl-L-leucylglycyl-L-lysyl-L-arginyl-L-tyrosyl-L-lysyl-L-glutaminyl-L-arginyl-L-valyl-L-lysyl-L-asparaginyl-
L-Lysinamide, L-glutaminyl-L-methionyl-L-alanyl-L-valyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-alanyl-L-alanyl-L-valyl-L-leucylglycyl-L-lysyl-L-arginyl-L-tyrosyl-L-lysyl-L-glutaminyl-L-arginyl-L-valyl-L-lysyl-L-asparaginyl- (9CI) | [Molecular Formula]
C123H215N39O28S | [MDL Number]
MFCD00080051 | [MOL File]
144025-82-1.mol | [Molecular Weight]
2720.33 |
| Hazard Information | Back Directory | [Uses]
PACAP-38 (16-38), human, mouse, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production[1]. PACAP is a potent activator of cAMP formation[2]. | [References]
[1] Braas KM, et al. Pituitary adenylate cyclase-activating polypeptides, PACAP-38 and PACAP-27, regulation of sympathetic neuron catecholamine, and neuropeptide Y expression through activation of type I PACAP/VIP receptor isoforms. Ann N Y Acad Sci. 1996 Dec 26;805:204-16. DOI:10.1111/j.1749-6632.1996.tb17484.x
[2] Lania A, et al. Mechanism of action of pituitary adenylate cyclase-activating polypeptide (PACAP) in human nonfunctioning pituitary tumors. J Neuroendocrinol. 1995 Sep;7(9):695-702. DOI:10.1111/j.1365-2826.1995.tb00811.x |
|
|